36th World Congress of Neuropsychopharmacology | 9th AsCNP Congress
The World Congress of Neuropsychopharmacology returns to Australia for the first time in nearly 30 years. CINP-AsCNP 2025, the 36TH World Congress, will be held at the Melbourne Convention and Exhibition Centre from Sunday, June 15TH to Wednesday, June 18TH, 2025, around the theme ‘Advancing Intelligent Horizons Towards Brain Health’.
With the development of science and technology in recent years, efforts to apply neuropsychopharmacology to clinical practice in neuropsychiatric disorders have flourished worldwide.
There have been many important developments within Australia, which has developed a youth mental health paradigm and clinical staging for early psychosis including at risk states. Moreover, Australia is the first country to permit the use of psilocybin assisted therapy for treatment resistant depression and MDMA assisted therapy for post-traumatic stress disorder (July 2023) and has also pioneered trials in psilocybin assisted therapy for generalised anxiety disorder.
CINP-AsCNP2025 will bring together experts from research and medical institutions, leading worldwide regulatory authorities and major pharmaceutical firms to promote basic and clinical research and to create a framework for a cohesive collaboration between academia, industry and governmental institutions toward the development and appropriate use of central nervous system drugs.
